D. E. Shaw & Co., Inc. Bio Techne Corp Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 44,591 shares of TECH stock, worth $2.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,591

Holding current value

$2.83 Million

% of portfolio

0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$46.66 - $58.38 $2.08 Million - $2.6 Million	44,591 New	44,591 $2.29 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $208,039 - $281,818	3,349 New	3,349 $239,000
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $1.28 Million - $1.69 Million	18,886 Added 23.72%	98,496 $6.7 Million
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $18.4 Million - $21.5 Million	-249,564 Reduced 75.82%	79,610 $6.5 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $22.1 Million - $26.7 Million	308,681 Added 1506.28%	329,174 $24.4 Million
Q4 2022 Feb 14, 2023	SELL	$80.67 - $352.29 $1.06 Million - $4.62 Million	-13,128 Reduced 39.05%	20,493 $1.7 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $391,600 - $543,104	-1,386 Reduced 3.96%	33,621 $9.55 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $6.36 Million - $8.86 Million	19,709 Added 128.83%	35,007 $12.1 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $1.58 Million - $2.18 Million	4,470 Added 41.28%	15,298 $6.62 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $879,457 - $1.01 Million	1,928 Added 21.66%	10,828 $5.6 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $1.07 Million - $1.3 Million	2,411 Added 37.16%	8,900 $4.31 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $1.25 Million - $1.46 Million	-3,238 Reduced 33.29%	6,489 $2.92 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $359,925 - $470,184	-1,144 Reduced 10.52%	9,727 $3.72 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $1.79 Million - $2.34 Million	-7,261 Reduced 40.05%	10,871 $3.45 Million
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $892,653 - $1.09 Million	3,844 Added 26.9%	18,132 $4.49 Million
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $8.78 Million - $13.2 Million	-47,354 Reduced 76.82%	14,288 $3.77 Million
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $2.39 Million - $3.28 Million	-14,802 Reduced 19.36%	61,642 $11.7 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $306,333 - $358,675	1,615 Added 2.16%	76,444 $16.8 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $3.91 Million - $4.61 Million	21,278 Added 39.73%	74,829 $14.6 Million
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $1.8 Million - $2.06 Million	9,563 Added 21.74%	53,551 $11.2 Million
Q1 2019 May 15, 2019	SELL	$136.09 - $200.44 $4.57 Million - $6.73 Million	-33,559 Reduced 43.28%	43,988 $8.73 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $8.23 Million - $12.6 Million	62,029 Added 399.72%	77,547 $11.2 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $2.71 Million - $3.75 Million	-18,370 Reduced 54.21%	15,518 $3.17 Million
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $479,184 - $547,573	3,307 Added 10.81%	33,888 $5.01 Million
Q1 2018 May 15, 2018	SELL	$131.46 - $151.04 $1.56 Million - $1.79 Million	-11,840 Reduced 27.91%	30,581 $4.62 Million
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $1.42 Million - $1.58 Million	11,737 Added 38.25%	42,421 $5.5 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $3.49 Million - $3.8 Million	30,684	30,684 $3.71 Million

Others Institutions Holding TECH

# of Institutions

613

Shares Held

161M

Call Options Held

225K

Put Options Held

80.8K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.49B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account